Orient Pharma Co., Ltd. (TPEX: 4166)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
25.70
-0.20 (-0.77%)
Oct 9, 2024, 2:01 PM CST

Orient Pharma Company Description

Orient Pharma Co., Ltd. engages in the research and development, manufacturing, and sales of drugs in Taiwan and internationally.

The company develops anti-psychotics and psychostimulants, as well as drugs for treating Parkinson’s and Alzheimer’s diseases; and products for the treatment of sialorrhea, tuberculosis, and attention deficit hyperactivity disorder.

It is also developing drug delivery technologies, such as multi-stages-controlled release technology, trans-dermal patches, oral disintegrating tablets, sustained release technology, and micro granules.

The company was founded in 2008 and is based in Taipei, Taiwan.

Orient Pharma Co., Ltd.
Country Taiwan
Founded 2008
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 173

Contact Details

Address:
No. 368, Fu Hsing South Road
Taipei, 106
Taiwan
Phone 886 2 2325 7621
Website oppharma.com

Stock Details

Ticker Symbol 4166
Exchange Taipei Exchange
Fiscal Year January - December
Reporting Currency TWD
ISIN Number TW0004166004
SIC Code 2834

Key Executives

Name Position
Yi Xin Zhang Chief Financial Officer
Zhi Cheng Lu Chief Operating Officer
Calvin Tsai GM and Director